PBSFY yields 0.93% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, PBSFY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PBSFY + PFE for your $10,000?
ProSiebenSat.1 Media SE, together with its subsidiaries, operates as a media company in Europe. It operates through three segments: Entertainment, Dating & Video, and Commerce & Ventures. The Entertainment segment operates free TV stations and digital paltforms, such as SAT.1, ProSieben, Kabel Eins, sixx, SAT.1 Gold, ProSieben MAXX, and Kabel Eins Doku, as well as distributes ProSiebenSat.1 HD stations. This segment is also involved in operating Marktguru and wetter.com; commercial websites; production and distribution programming portfolio, including entertainment, reality, and factual formats, as well as TV series, TV movies, and digital content; and operates Studio71, which offers digital content and web productions covering branded content, original production, content distribution, influencer products, and creator management. The Dating & Video segment engages in online matchmaking services for social dating and entertainment under the Parship, ElitePartner, eHarmony, LOVOO help singles brand names. This segment also provides video-based social dating and entertainment applications, such as MeetMe, Skout, Tagged, and GROWLr content for users. The Commerce & Ventures segment engages in the consumer advice, experiences, and beauty and lifestyle businesses; and offers individual tailored support services for development of companies. ProSiebenSat.1 Media SE was founded in 1984 and is headquartered in Unterföhring, Germany.
Full PBSFY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.